GB9721171D0 - Therapeutic use - Google Patents

Therapeutic use

Info

Publication number
GB9721171D0
GB9721171D0 GB9721171A GB9721171A GB9721171D0 GB 9721171 D0 GB9721171 D0 GB 9721171D0 GB 9721171 A GB9721171 A GB 9721171A GB 9721171 A GB9721171 A GB 9721171A GB 9721171 D0 GB9721171 D0 GB 9721171D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic use
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB9721171A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Priority to GB9721171A priority Critical patent/GB9721171D0/en
Priority to DK97952020T priority patent/DK0942729T3/en
Priority to ES97952020T priority patent/ES2227728T3/en
Priority to PCT/EP1997/006684 priority patent/WO1998024440A1/en
Priority to AT97952020T priority patent/ATE274908T1/en
Priority to AU55590/98A priority patent/AU731676B2/en
Priority to PT97952020T priority patent/PT942729E/en
Priority to DE69730515T priority patent/DE69730515T2/en
Priority to JP52517198A priority patent/JP2001504849A/en
Priority to CA002273786A priority patent/CA2273786A1/en
Priority to EP97952020A priority patent/EP0942729B1/en
Publication of GB9721171D0 publication Critical patent/GB9721171D0/en
Priority to CY0500004A priority patent/CY2499B1/en
Ceased legal-status Critical Current

Links

GB9721171A 1996-12-02 1997-10-07 Therapeutic use Ceased GB9721171D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GB9721171A GB9721171D0 (en) 1997-10-07 1997-10-07 Therapeutic use
AU55590/98A AU731676B2 (en) 1996-12-02 1997-11-25 Use of NK-1 receptor antagonists for treating stress disorders
ES97952020T ES2227728T3 (en) 1996-12-02 1997-11-25 USE OF NK-1 RECEIVER ANTAGONISTS TO TREAT ESTS DISORDERS.
PCT/EP1997/006684 WO1998024440A1 (en) 1996-12-02 1997-11-25 Use of nk-1 receptor antagonists for treating stress disorders
AT97952020T ATE274908T1 (en) 1996-12-02 1997-11-25 THE USE OF NK-1 RECEPTOR ANTAGONISTS FOR THE TREATMENTS OF STRESS DISORDERS
DK97952020T DK0942729T3 (en) 1996-12-02 1997-11-25 Use of NK-1 receptor antagonists for the treatment of stress disorders
PT97952020T PT942729E (en) 1996-12-02 1997-11-25 UTILIZATION OF NK-1 RECEPTOR ANTAGONISTS FOR TREATMENT OF STRESSE DISEASES
DE69730515T DE69730515T2 (en) 1996-12-02 1997-11-25 THE USE OF NK-1 RECEPTOR ANTAGONISTS FOR THE TREATMENTS OF STRESS DISORDERS
JP52517198A JP2001504849A (en) 1996-12-02 1997-11-25 Use of an NK-1 receptor antagonist for the treatment of stress disorders
CA002273786A CA2273786A1 (en) 1996-12-02 1997-11-25 Use of nk-1 receptor antagonists for treating stress disorders
EP97952020A EP0942729B1 (en) 1996-12-02 1997-11-25 Use of nk-1 receptor antagonists for treating stress disorders
CY0500004A CY2499B1 (en) 1996-12-02 2005-01-10 Use of nk-1 receptor antagonists for treating stress disorders.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9721171A GB9721171D0 (en) 1997-10-07 1997-10-07 Therapeutic use

Publications (1)

Publication Number Publication Date
GB9721171D0 true GB9721171D0 (en) 1997-12-03

Family

ID=10820119

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9721171A Ceased GB9721171D0 (en) 1996-12-02 1997-10-07 Therapeutic use

Country Status (1)

Country Link
GB (1) GB9721171D0 (en)

Similar Documents

Publication Publication Date Title
GB9708484D0 (en) Therapeutic agents
GB9708945D0 (en) Therapeutic agents
GB9704948D0 (en) Therapeutic agents
GB9702524D0 (en) Therapeutic agents
ZA982368B (en) New therapeutic combinations
GB9711753D0 (en) Therapeutic agents
GB9713707D0 (en) Therapeutic agents
GB9715977D0 (en) Therapeutic agents
GB9711114D0 (en) Therapeutic agents
GB9702392D0 (en) Therapeutic agents
GB9620777D0 (en) Therapeutic use
GB9700555D0 (en) Therapeutic agents
GB9723999D0 (en) Therapeutic use
GB9726701D0 (en) Therapeutic use
GB9726702D0 (en) Therapeutic use
GB9716457D0 (en) Therapeutic agents
GB9721190D0 (en) Therapeutic use
GB9717260D0 (en) Therapeutic use
GB9721266D0 (en) Therapeutic use
GB9721195D0 (en) Therapeutic use
GB9721179D0 (en) Therapeutic use
GB9726700D0 (en) Therapeutic use
GB9721194D0 (en) Therapeutic use
GB9721177D0 (en) Therapeutic use
GB9721221D0 (en) Therapeutic use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)